August 29, 2022
Via: Drugs.comU.S. doctors administered more than 150,000 doses of useless monoclonal antibody treatments to COVID-19 patients early this year, spending loads of cash on therapies that had been deemed of no benefit, a new study has found. The U.S. Food and […]
January 24, 2022
Via: Drugs.comThe U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant. The treatments made by Regeneron and Eli Lilly performed well against earlier […]
July 11, 2024
July 11, 2024
July 19, 2024